Kentfield Rehabilation is categorized under Physical Medicine, Physician/Surgeon in Petaluma, CA and active since 2004.
Kentfield Rehabilation was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ann Goors at the company’s single location by writing to 191 Lynch Creek Way # 201, Petaluma, California CA 94954 or by phoning (209) 887-3603. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kentfield Rehabilation |
| Contact Person: | Ann Goors |
| Address: | 191 Lynch Creek Way # 201, Petaluma, California 94954 |
| Phone Number: | (209) 887-3603 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Kentfield Rehabilation was started in 2004 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ann Goors for inquiries that concern Kentfield Rehabilation by calling the company number (209) 887-3603, as your correspondence is most welcome. Additionally, the physical location of the single location of Kentfield Rehabilation can be found at the coordinates as well as the street address 191 Lynch Creek Way # 201 in Petaluma, California 94954.
For its online presence, you may visit Kentfield Rehabilation’s website at and engage with its social media outlets through on Twitter and on Facebook.